Skila’s Karen Massand to Participate in Panel Discussion at 18th Annual NYBA 2009 Meeting

April 16, 2009 - PRLog -- Skila’s Karen Massand, Managing Director Strategic Advisory, will participate in a panel discussion, “Pharma & Biotech on the Web” at the New York Biotechnology Association (NYBA) 18th Annual Meeting being held in New York City on April 21, 2009,.

The panel will discuss the latest trends and future of the web as a major component of pharmaceutical and biotechnology companies’ operations and marketing strategies. Skila’s Karen Massand will discuss how life science organizations can become “partners of choice” and maximize alliances by leveraging the web for successful alliance management.  

“A critical component of being partner focused and building strong alliance relationships is transparency,” says Karen Massand, Managing Director Strategic Advisory Services, Skila.  “Web technology facilitates that transparency, allowing partners to optimize collaboration and build trust. Alliance partners that foster open communication, ensure alliance commitments are met and continuously monitor alliance health are ‘Partners of Choice’."

The NYBA 18th Annual Meeting will take place April 20 and 21, 2009 at the Marriott Marquis Hotel in New York City and will have a special focus on partnering between emerging biotech companies and large bio and pharmaceutical corporations. Highlights of the Annual Meeting will include a keynote address by Billy Tauzin, CEO of PhRMA (Pharmaceutical Research and Manufacturers Association) and an important plenary roundtable featuring senior licensing and business development executives from Merck, Pfizer and other major companies.


To register for the event, visit: http://www.nyba.org/annual-meeting.php

About Skila
Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, managed markets, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients. To learn more about Skila visit our website at www.skila.com.

# # #

Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, executive and alliance management teams.